Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The livestock vaccine market is predicted to be valued at US$ 6.1 billion in 2024 and rise to US$ 11.2 billion by 2034. The market is expected to grow at a CAGR of 6.2% during the forecast period.
Key Market Drivers
With the objective of giving the animal a vaccine to stimulate the immune system to form antibodies for the upliftment of their well-being, there is a huge rise in the livestock vaccine market. Some factors are mentioned below-
Attributes | Key Statistics |
---|---|
Live Stock Vaccine Market Value (2024) | US$ 6.1 billion |
Anticipated Market Value (2034) | US$ 11.2 billion |
Estimated Growth (2024 to 2034) | 6.2 % CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Despite the healthy growth of the livestock vaccine market in healthcare sectors, several factors are slowing down the market.
The section has revealed two markets that could pose stiff competition to the vaccine market: the vaccines market and the influenza vaccine market.
The tables below outline these markets' current market valuations and growth rates. The report also discusses the growth drivers and critical challenges faced by each market.
Live Stock Vaccine Market:
Attributes | Live Stock Vaccine Market |
---|---|
CAGR (2024 to 2034) | 6.2% |
Market Value (2034) | US$ 11.2 billion |
Growth Factor | Expansion of the livestock industry in emerging markets |
Key Challenges | Limited awareness among producers and infrastructure constraints. |
Vaccines Market:
Attributes | Vaccines Market |
---|---|
CAGR (2023 to 2033) | 6.6 % |
Market Value (2033) | US$ 80.8 billion |
Growth Factor | Increased healthcare budget post-pandemic along with the extended research and development programs |
Key Challenges | Supply chain constraints, emerging infectious diseases, and equitable distribution |
Influenza Vaccine Market:
Attributes | Influenza Vaccine Market |
---|---|
CAGR (2023 to 2033) | 8.8% |
Market Value (2033) | US$ 18.89 billion |
Growth Factor | Development of combination vaccines along with the development of mRNA vaccines |
Key Challenges | Antigenic variability leading to the need for annual vaccine reformulation |
Inactivate vaccines ensure quality assurance and validation, upsurging the global livestock vaccine market with a 6.0% CAGR through 2034.
Attributes | Details |
---|---|
Top Type | Inactivated |
CAGR (2024 to 2034) | 6.0% |
Bovine vaccines are crucial in economic and productivity concerns, heightening the global livestock vaccine market by 5.8% CAGR from 2024 to 2034.
Attributes | Details |
---|---|
Top Animal Type | Bovine |
CAGR (2024 to 2034) | 5.8% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section analyzes the global livestock vaccine market by country, including the United Kingdom, the United States, China, South Korea, and Japan.
The table presents the CAGR for each country, indicating the expected market growth through 2034.
Countries | CAGR (2024 to 2034) |
---|---|
South Korea | 8.0% |
Japan | 7.9% |
United Kingdom | 7.4% |
China | 6.8% |
United States | 6.4% |
With growing demand for personalized medicine and advancements in precision healthcare, South Korea is well-positioned to capitalize on the opportunities presented by the expanding global livestock vaccine market with a CAGR of 8.0% from 2024 to 2034.
South Korea is investing in research and development to create innovative vaccine solutions to cater to the needs of the livestock sector. The market presents opportunities for collaborations with global vaccine manufacturers to introduce advanced technologies, expansion of vaccine production capabilities to meet both domestic and international demand, and the adoption of digital solutions for efficient vaccine distribution and administration.
South Korea's innovation in the field includes the development of novel vaccine delivery systems such as edible vaccines that offer convenience and improved efficacy. Future plans involve partnerships between public and private sectors to establish advance vaccine manufacturing facilities and enhance biosecurity measures to prevent disease outbreaks.
Japan is flourishing in the livestock vaccine market due to the country's growing emphasis on food safety, animal health, and sustainable agriculture. The market has a CAGR of 7.9%, which is expected to continue through 2034.
Japan is investing heavily in research and development, with a particular focus on improving the efficacy and safety of livestock vaccines. Collaboration between government agencies, academic institutions, and pharmaceutical companies is also on the rise, as they work together to create innovative vaccine solutions customized to meet the unique needs of the local livestock industry.
Notable organizations driving this growth include the National Institute of Animal Health and the Japan Livestock Technology Association, both actively engaged in vaccine research and development.
The livestock vaccine market in the United Kingdom is projected to expand at a CAGR of 7.4% through 2034.
The United Kingdom is expanding with increased awareness of animal health and welfare. Growing Concerns about zoonotic diseases and government initiatives to support sustainable agriculture are uplifting the market growth. The United Kingdom is approaching this expansion by investing in research and development, fostering collaborations between academia and industry, and implementing regulatory measures to ensure the safety and efficacy of veterinary vaccines.
Famous centers such as the Pirbright Institute and the Roslin Institute play a crucial role in vaccine research and development, contributing to the expansion of the market. Upcoming projects like the United Kingdom Vaccine Manufacturing and Innovation Centre (VMIC) aim to strengthen the country's vaccine manufacturing capabilities and support the production of vaccines for livestock diseases.
China is emerging as a key player in the livestock vaccine market. The market is projected to rise at a CAGR of 6.8% from 2024 to 2034. China is in a steady race to improve its veterinary healthcare sector.
Chinese government has made considerable efforts and investments in veterinary vaccines, prioritizing the health of livestock and food safety. These initiatives include research and development aimed at innovating vaccine formulations to tackle local disease challenges and production systems.
China has been actively promoting the use of vaccination programs among livestock producers through subsidies and educational campaigns, resulting in increased adoption rates. The demand for animal protein is also on the rise, along with the growth of the livestock industry leading to an escalating need for effective disease prevention measures in China.
Ongoing advancement and research in the United States soar market growth, with an expected CAGR of 6.4% until 2034.
The livestock vaccine market in the United States is expanding due to several factors. Innovative developments in veterinary vaccines, such as the introduction of novel formulations and delivery methods, have spurred growth by enhancing vaccine efficacy and safety. Research projects focused on improving disease prevention and management have contributed to market expansion, with initiatives aimed at addressing emerging livestock diseases and increasing vaccine accessibility.
Notable companies driving this growth include Zoetis, Merck Animal Health, and Elanco, which have a strong presence in the United States to develop cutting-edge vaccine solutions tailored to the needs of American livestock producers.
Manufacturers and major companies are taking proactive measures to expand their market presence, as they are witnessing high demand in the livestock vaccine market. Companies such as Zoetis, Merck Animal Health, and Elanco are investing in research and development to create innovative vaccine formulations and delivery methods, which enhance the efficacy and safety of the vaccines.
With the growing global demand for protein-rich diets and increased awareness of animal health and welfare, there are significant opportunities for manufacturers to capitalize on the expanding livestock vaccine market. Some of the emerging trends in this market, such as personalized vaccination programs and the development of vaccines for emerging diseases, present promising avenues for growth and differentiation.
Recent Developments
The livestock vaccine market is projected to be worth US$ 6.1 billion in 2024.
The market is expected to reach US$ 11.2 billion by 2034.
The market is expected to grow at a CAGR of 6.2% from 2024 to 2034.
Boehringer Ingelheim International GmbH, Virbac, Merck Animal Health, Ceva, and Elanco are among the major companies actively contributing to the growth of the global livestock vaccine market.
Increasing demand for animal protein is accelerating the demand for livestock vaccines.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.1.2. Mid-Level Participants (Traders) 3.5.1.3. Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Distributors 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Vials) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Type, 2024 to 2034 5.3.1. Inactivated 5.3.2. Live Attenuated 5.3.3. Recombinant 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Animal Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Animal Type, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Animal Type, 2024 to 2034 6.3.1. Bovine 6.3.2. Swine/ Porcine 6.3.3. Poultry 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Animal Type, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Animal Type, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Route of Administration, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Route of Administration, 2024 to 2034 7.3.1. Oral 7.3.2. Parenteral 7.3.3. Others 7.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Route of Administration, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Distribution Channel, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Distribution Channel, 2024 to 2034 8.3.1. Veterinary Hospitals 8.3.2. Veterinary Clinics 8.3.3. Others 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Region, 2019 to 2023 9.3. Current Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Region, 2024 to 2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Type 10.2.3. By Animal Type 10.2.4. By Route of Administration 10.2.5. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Animal Type 10.3.4. By Route of Administration 10.3.5. By Distribution Channel 10.4. Key Takeaways 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Type 11.2.3. By Animal Type 11.2.4. By Route of Administration 11.2.5. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Animal Type 11.3.4. By Route of Administration 11.3.5. By Distribution Channel 11.4. Key Takeaways 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Type 12.2.3. By Animal Type 12.2.4. By Route of Administration 12.2.5. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Animal Type 12.3.4. By Route of Administration 12.3.5. By Distribution Channel 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Type 13.2.3. By Animal Type 13.2.4. By Route of Administration 13.2.5. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Animal Type 13.3.4. By Route of Administration 13.3.5. By Distribution Channel 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Type 14.2.3. By Animal Type 14.2.4. By Route of Administration 14.2.5. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Animal Type 14.3.4. By Route of Administration 14.3.5. By Distribution Channel 14.4. Key Takeaways 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Type 15.2.3. By Animal Type 15.2.4. By Route of Administration 15.2.5. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Type 15.3.3. By Animal Type 15.3.4. By Route of Administration 15.3.5. By Distribution Channel 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Type 16.2.3. By Animal Type 16.2.4. By Route of Administration 16.2.5. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Type 16.3.3. By Animal Type 16.3.4. By Route of Administration 16.3.5. By Distribution Channel 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2023 17.1.2.1. By Type 17.1.2.2. By Animal Type 17.1.2.3. By Route of Administration 17.1.2.4. By Distribution Channel 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2023 17.2.2.1. By Type 17.2.2.2. By Animal Type 17.2.2.3. By Route of Administration 17.2.2.4. By Distribution Channel 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2023 17.3.2.1. By Type 17.3.2.2. By Animal Type 17.3.2.3. By Route of Administration 17.3.2.4. By Distribution Channel 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2023 17.4.2.1. By Type 17.4.2.2. By Animal Type 17.4.2.3. By Route of Administration 17.4.2.4. By Distribution Channel 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2023 17.5.2.1. By Type 17.5.2.2. By Animal Type 17.5.2.3. By Route of Administration 17.5.2.4. By Distribution Channel 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2023 17.6.2.1. By Type 17.6.2.2. By Animal Type 17.6.2.3. By Route of Administration 17.6.2.4. By Distribution Channel 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2023 17.7.2.1. By Type 17.7.2.2. By Animal Type 17.7.2.3. By Route of Administration 17.7.2.4. By Distribution Channel 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2023 17.8.2.1. By Type 17.8.2.2. By Animal Type 17.8.2.3. By Route of Administration 17.8.2.4. By Distribution Channel 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2023 17.9.2.1. By Type 17.9.2.2. By Animal Type 17.9.2.3. By Route of Administration 17.9.2.4. By Distribution Channel 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2023 17.10.2.1. By Type 17.10.2.2. By Animal Type 17.10.2.3. By Route of Administration 17.10.2.4. By Distribution Channel 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2023 17.11.2.1. By Type 17.11.2.2. By Animal Type 17.11.2.3. By Route of Administration 17.11.2.4. By Distribution Channel 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2023 17.12.2.1. By Type 17.12.2.2. By Animal Type 17.12.2.3. By Route of Administration 17.12.2.4. By Distribution Channel 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2023 17.13.2.1. By Type 17.13.2.2. By Animal Type 17.13.2.3. By Route of Administration 17.13.2.4. By Distribution Channel 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2023 17.14.2.1. By Type 17.14.2.2. By Animal Type 17.14.2.3. By Route of Administration 17.14.2.4. By Distribution Channel 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2023 17.15.2.1. By Type 17.15.2.2. By Animal Type 17.15.2.3. By Route of Administration 17.15.2.4. By Distribution Channel 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2023 17.16.2.1. By Type 17.16.2.2. By Animal Type 17.16.2.3. By Route of Administration 17.16.2.4. By Distribution Channel 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2023 17.17.2.1. By Type 17.17.2.2. By Animal Type 17.17.2.3. By Route of Administration 17.17.2.4. By Distribution Channel 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2023 17.18.2.1. By Type 17.18.2.2. By Animal Type 17.18.2.3. By Route of Administration 17.18.2.4. By Distribution Channel 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2023 17.19.2.1. By Type 17.19.2.2. By Animal Type 17.19.2.3. By Route of Administration 17.19.2.4. By Distribution Channel 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2023 17.20.2.1. By Type 17.20.2.2. By Animal Type 17.20.2.3. By Route of Administration 17.20.2.4. By Distribution Channel 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2023 17.21.2.1. By Type 17.21.2.2. By Animal Type 17.21.2.3. By Route of Administration 17.21.2.4. By Distribution Channel 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2023 17.22.2.1. By Type 17.22.2.2. By Animal Type 17.22.2.3. By Route of Administration 17.22.2.4. By Distribution Channel 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2023 17.23.2.1. By Type 17.23.2.2. By Animal Type 17.23.2.3. By Route of Administration 17.23.2.4. By Distribution Channel 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Type 18.3.3. By Animal Type 18.3.4. By Route of Administration 18.3.5. By Distribution Channel 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Boehringer Ingelheim International GmbH 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.1.5.2. Product Strategy 19.1.1.5.3. Channel Strategy 19.1.2. Virbac 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.2.5.2. Product Strategy 19.1.2.5.3. Channel Strategy 19.1.3. Merck Animal Health (Merck & Co., Inc.) 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.3.5.2. Product Strategy 19.1.3.5.3. Channel Strategy 19.1.4. Zoetis Services LLC 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.4.5.2. Product Strategy 19.1.4.5.3. Channel Strategy 19.1.5. Ceva 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.5.5.2. Product Strategy 19.1.5.5.3. Channel Strategy 19.1.6. Elanco 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.6.5.2. Product Strategy 19.1.6.5.3. Channel Strategy 19.1.7. HIPRA 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.7.5.2. Product Strategy 19.1.7.5.3. Channel Strategy 19.1.8. Neogen Corporation 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.8.5.2. Product Strategy 19.1.8.5.3. Channel Strategy 19.1.9. Dechra Pharmaceuticals PLC 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.9.5.2. Product Strategy 19.1.9.5.3. Channel Strategy 19.1.10. Biogénesis Bagó 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.10.5.2. Product Strategy 19.1.10.5.3. Channel Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034 Table 2: Global Market Volume (Vials) Forecast by Region, 2019 to 2034 Table 3: Global Market Value (US$ Million) Forecast by Type, 2019 to 2034 Table 4: Global Market Volume (Vials) Forecast by Type, 2019 to 2034 Table 5: Global Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034 Table 6: Global Market Volume (Vials) Forecast by Animal Type, 2019 to 2034 Table 7: Global Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034 Table 8: Global Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034 Table 9: Global Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 10: Global Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034 Table 11: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 12: North America Market Volume (Vials) Forecast by Country, 2019 to 2034 Table 13: North America Market Value (US$ Million) Forecast by Type, 2019 to 2034 Table 14: North America Market Volume (Vials) Forecast by Type, 2019 to 2034 Table 15: North America Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034 Table 16: North America Market Volume (Vials) Forecast by Animal Type, 2019 to 2034 Table 17: North America Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034 Table 18: North America Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034 Table 19: North America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 20: North America Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034 Table 21: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 22: Latin America Market Volume (Vials) Forecast by Country, 2019 to 2034 Table 23: Latin America Market Value (US$ Million) Forecast by Type, 2019 to 2034 Table 24: Latin America Market Volume (Vials) Forecast by Type, 2019 to 2034 Table 25: Latin America Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034 Table 26: Latin America Market Volume (Vials) Forecast by Animal Type, 2019 to 2034 Table 27: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034 Table 28: Latin America Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034 Table 29: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 30: Latin America Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034 Table 31: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 32: Western Europe Market Volume (Vials) Forecast by Country, 2019 to 2034 Table 33: Western Europe Market Value (US$ Million) Forecast by Type, 2019 to 2034 Table 34: Western Europe Market Volume (Vials) Forecast by Type, 2019 to 2034 Table 35: Western Europe Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034 Table 36: Western Europe Market Volume (Vials) Forecast by Animal Type, 2019 to 2034 Table 37: Western Europe Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034 Table 38: Western Europe Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034 Table 39: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 40: Western Europe Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034 Table 41: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 42: Eastern Europe Market Volume (Vials) Forecast by Country, 2019 to 2034 Table 43: Eastern Europe Market Value (US$ Million) Forecast by Type, 2019 to 2034 Table 44: Eastern Europe Market Volume (Vials) Forecast by Type, 2019 to 2034 Table 45: Eastern Europe Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034 Table 46: Eastern Europe Market Volume (Vials) Forecast by Animal Type, 2019 to 2034 Table 47: Eastern Europe Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034 Table 48: Eastern Europe Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034 Table 49: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 50: Eastern Europe Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034 Table 51: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 52: South Asia and Pacific Market Volume (Vials) Forecast by Country, 2019 to 2034 Table 53: South Asia and Pacific Market Value (US$ Million) Forecast by Type, 2019 to 2034 Table 54: South Asia and Pacific Market Volume (Vials) Forecast by Type, 2019 to 2034 Table 55: South Asia and Pacific Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034 Table 56: South Asia and Pacific Market Volume (Vials) Forecast by Animal Type, 2019 to 2034 Table 57: South Asia and Pacific Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034 Table 58: South Asia and Pacific Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034 Table 59: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 60: South Asia and Pacific Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034 Table 61: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 62: East Asia Market Volume (Vials) Forecast by Country, 2019 to 2034 Table 63: East Asia Market Value (US$ Million) Forecast by Type, 2019 to 2034 Table 64: East Asia Market Volume (Vials) Forecast by Type, 2019 to 2034 Table 65: East Asia Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034 Table 66: East Asia Market Volume (Vials) Forecast by Animal Type, 2019 to 2034 Table 67: East Asia Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034 Table 68: East Asia Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034 Table 69: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 70: East Asia Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034 Table 71: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 72: Middle East and Africa Market Volume (Vials) Forecast by Country, 2019 to 2034 Table 73: Middle East and Africa Market Value (US$ Million) Forecast by Type, 2019 to 2034 Table 74: Middle East and Africa Market Volume (Vials) Forecast by Type, 2019 to 2034 Table 75: Middle East and Africa Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034 Table 76: Middle East and Africa Market Volume (Vials) Forecast by Animal Type, 2019 to 2034 Table 77: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034 Table 78: Middle East and Africa Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034 Table 79: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 80: Middle East and Africa Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Type, 2024 to 2034 Figure 2: Global Market Value (US$ Million) by Animal Type, 2024 to 2034 Figure 3: Global Market Value (US$ Million) by Route of Administration, 2024 to 2034 Figure 4: Global Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 5: Global Market Value (US$ Million) by Region, 2024 to 2034 Figure 6: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034 Figure 7: Global Market Volume (Vials) Analysis by Region, 2019 to 2034 Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034 Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034 Figure 10: Global Market Value (US$ Million) Analysis by Type, 2019 to 2034 Figure 11: Global Market Volume (Vials) Analysis by Type, 2019 to 2034 Figure 12: Global Market Value Share (%) and BPS Analysis by Type, 2024 to 2034 Figure 13: Global Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034 Figure 14: Global Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034 Figure 15: Global Market Volume (Vials) Analysis by Animal Type, 2019 to 2034 Figure 16: Global Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034 Figure 17: Global Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034 Figure 18: Global Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034 Figure 19: Global Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034 Figure 20: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034 Figure 21: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034 Figure 22: Global Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 23: Global Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034 Figure 24: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 25: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 26: Global Market Attractiveness by Type, 2024 to 2034 Figure 27: Global Market Attractiveness by Animal Type, 2024 to 2034 Figure 28: Global Market Attractiveness by Route of Administration, 2024 to 2034 Figure 29: Global Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 30: Global Market Attractiveness by Region, 2024 to 2034 Figure 31: North America Market Value (US$ Million) by Type, 2024 to 2034 Figure 32: North America Market Value (US$ Million) by Animal Type, 2024 to 2034 Figure 33: North America Market Value (US$ Million) by Route of Administration, 2024 to 2034 Figure 34: North America Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 35: North America Market Value (US$ Million) by Country, 2024 to 2034 Figure 36: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 37: North America Market Volume (Vials) Analysis by Country, 2019 to 2034 Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 40: North America Market Value (US$ Million) Analysis by Type, 2019 to 2034 Figure 41: North America Market Volume (Vials) Analysis by Type, 2019 to 2034 Figure 42: North America Market Value Share (%) and BPS Analysis by Type, 2024 to 2034 Figure 43: North America Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034 Figure 44: North America Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034 Figure 45: North America Market Volume (Vials) Analysis by Animal Type, 2019 to 2034 Figure 46: North America Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034 Figure 47: North America Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034 Figure 48: North America Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034 Figure 49: North America Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034 Figure 50: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034 Figure 51: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034 Figure 52: North America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 53: North America Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034 Figure 54: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 55: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 56: North America Market Attractiveness by Type, 2024 to 2034 Figure 57: North America Market Attractiveness by Animal Type, 2024 to 2034 Figure 58: North America Market Attractiveness by Route of Administration, 2024 to 2034 Figure 59: North America Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 60: North America Market Attractiveness by Country, 2024 to 2034 Figure 61: Latin America Market Value (US$ Million) by Type, 2024 to 2034 Figure 62: Latin America Market Value (US$ Million) by Animal Type, 2024 to 2034 Figure 63: Latin America Market Value (US$ Million) by Route of Administration, 2024 to 2034 Figure 64: Latin America Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 65: Latin America Market Value (US$ Million) by Country, 2024 to 2034 Figure 66: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 67: Latin America Market Volume (Vials) Analysis by Country, 2019 to 2034 Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 70: Latin America Market Value (US$ Million) Analysis by Type, 2019 to 2034 Figure 71: Latin America Market Volume (Vials) Analysis by Type, 2019 to 2034 Figure 72: Latin America Market Value Share (%) and BPS Analysis by Type, 2024 to 2034 Figure 73: Latin America Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034 Figure 74: Latin America Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034 Figure 75: Latin America Market Volume (Vials) Analysis by Animal Type, 2019 to 2034 Figure 76: Latin America Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034 Figure 77: Latin America Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034 Figure 78: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034 Figure 79: Latin America Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034 Figure 80: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034 Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034 Figure 82: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 83: Latin America Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034 Figure 84: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 85: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 86: Latin America Market Attractiveness by Type, 2024 to 2034 Figure 87: Latin America Market Attractiveness by Animal Type, 2024 to 2034 Figure 88: Latin America Market Attractiveness by Route of Administration, 2024 to 2034 Figure 89: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 90: Latin America Market Attractiveness by Country, 2024 to 2034 Figure 91: Western Europe Market Value (US$ Million) by Type, 2024 to 2034 Figure 92: Western Europe Market Value (US$ Million) by Animal Type, 2024 to 2034 Figure 93: Western Europe Market Value (US$ Million) by Route of Administration, 2024 to 2034 Figure 94: Western Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 95: Western Europe Market Value (US$ Million) by Country, 2024 to 2034 Figure 96: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 97: Western Europe Market Volume (Vials) Analysis by Country, 2019 to 2034 Figure 98: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 99: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 100: Western Europe Market Value (US$ Million) Analysis by Type, 2019 to 2034 Figure 101: Western Europe Market Volume (Vials) Analysis by Type, 2019 to 2034 Figure 102: Western Europe Market Value Share (%) and BPS Analysis by Type, 2024 to 2034 Figure 103: Western Europe Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034 Figure 104: Western Europe Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034 Figure 105: Western Europe Market Volume (Vials) Analysis by Animal Type, 2019 to 2034 Figure 106: Western Europe Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034 Figure 107: Western Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034 Figure 108: Western Europe Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034 Figure 109: Western Europe Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034 Figure 110: Western Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034 Figure 111: Western Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034 Figure 112: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 113: Western Europe Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034 Figure 114: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 115: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 116: Western Europe Market Attractiveness by Type, 2024 to 2034 Figure 117: Western Europe Market Attractiveness by Animal Type, 2024 to 2034 Figure 118: Western Europe Market Attractiveness by Route of Administration, 2024 to 2034 Figure 119: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 120: Western Europe Market Attractiveness by Country, 2024 to 2034 Figure 121: Eastern Europe Market Value (US$ Million) by Type, 2024 to 2034 Figure 122: Eastern Europe Market Value (US$ Million) by Animal Type, 2024 to 2034 Figure 123: Eastern Europe Market Value (US$ Million) by Route of Administration, 2024 to 2034 Figure 124: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 125: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034 Figure 126: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 127: Eastern Europe Market Volume (Vials) Analysis by Country, 2019 to 2034 Figure 128: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 129: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 130: Eastern Europe Market Value (US$ Million) Analysis by Type, 2019 to 2034 Figure 131: Eastern Europe Market Volume (Vials) Analysis by Type, 2019 to 2034 Figure 132: Eastern Europe Market Value Share (%) and BPS Analysis by Type, 2024 to 2034 Figure 133: Eastern Europe Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034 Figure 134: Eastern Europe Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034 Figure 135: Eastern Europe Market Volume (Vials) Analysis by Animal Type, 2019 to 2034 Figure 136: Eastern Europe Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034 Figure 137: Eastern Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034 Figure 138: Eastern Europe Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034 Figure 139: Eastern Europe Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034 Figure 140: Eastern Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034 Figure 141: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034 Figure 142: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 143: Eastern Europe Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034 Figure 144: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 145: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 146: Eastern Europe Market Attractiveness by Type, 2024 to 2034 Figure 147: Eastern Europe Market Attractiveness by Animal Type, 2024 to 2034 Figure 148: Eastern Europe Market Attractiveness by Route of Administration, 2024 to 2034 Figure 149: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 150: Eastern Europe Market Attractiveness by Country, 2024 to 2034 Figure 151: South Asia and Pacific Market Value (US$ Million) by Type, 2024 to 2034 Figure 152: South Asia and Pacific Market Value (US$ Million) by Animal Type, 2024 to 2034 Figure 153: South Asia and Pacific Market Value (US$ Million) by Route of Administration, 2024 to 2034 Figure 154: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 155: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034 Figure 156: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 157: South Asia and Pacific Market Volume (Vials) Analysis by Country, 2019 to 2034 Figure 158: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 159: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 160: South Asia and Pacific Market Value (US$ Million) Analysis by Type, 2019 to 2034 Figure 161: South Asia and Pacific Market Volume (Vials) Analysis by Type, 2019 to 2034 Figure 162: South Asia and Pacific Market Value Share (%) and BPS Analysis by Type, 2024 to 2034 Figure 163: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034 Figure 164: South Asia and Pacific Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034 Figure 165: South Asia and Pacific Market Volume (Vials) Analysis by Animal Type, 2019 to 2034 Figure 166: South Asia and Pacific Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034 Figure 167: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034 Figure 168: South Asia and Pacific Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034 Figure 169: South Asia and Pacific Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034 Figure 170: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034 Figure 171: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034 Figure 172: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 173: South Asia and Pacific Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034 Figure 174: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 175: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 176: South Asia and Pacific Market Attractiveness by Type, 2024 to 2034 Figure 177: South Asia and Pacific Market Attractiveness by Animal Type, 2024 to 2034 Figure 178: South Asia and Pacific Market Attractiveness by Route of Administration, 2024 to 2034 Figure 179: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 180: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034 Figure 181: East Asia Market Value (US$ Million) by Type, 2024 to 2034 Figure 182: East Asia Market Value (US$ Million) by Animal Type, 2024 to 2034 Figure 183: East Asia Market Value (US$ Million) by Route of Administration, 2024 to 2034 Figure 184: East Asia Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 185: East Asia Market Value (US$ Million) by Country, 2024 to 2034 Figure 186: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 187: East Asia Market Volume (Vials) Analysis by Country, 2019 to 2034 Figure 188: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 189: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 190: East Asia Market Value (US$ Million) Analysis by Type, 2019 to 2034 Figure 191: East Asia Market Volume (Vials) Analysis by Type, 2019 to 2034 Figure 192: East Asia Market Value Share (%) and BPS Analysis by Type, 2024 to 2034 Figure 193: East Asia Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034 Figure 194: East Asia Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034 Figure 195: East Asia Market Volume (Vials) Analysis by Animal Type, 2019 to 2034 Figure 196: East Asia Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034 Figure 197: East Asia Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034 Figure 198: East Asia Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034 Figure 199: East Asia Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034 Figure 200: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034 Figure 201: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034 Figure 202: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 203: East Asia Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034 Figure 204: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 205: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 206: East Asia Market Attractiveness by Type, 2024 to 2034 Figure 207: East Asia Market Attractiveness by Animal Type, 2024 to 2034 Figure 208: East Asia Market Attractiveness by Route of Administration, 2024 to 2034 Figure 209: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 210: East Asia Market Attractiveness by Country, 2024 to 2034 Figure 211: Middle East and Africa Market Value (US$ Million) by Type, 2024 to 2034 Figure 212: Middle East and Africa Market Value (US$ Million) by Animal Type, 2024 to 2034 Figure 213: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2024 to 2034 Figure 214: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 215: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034 Figure 216: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 217: Middle East and Africa Market Volume (Vials) Analysis by Country, 2019 to 2034 Figure 218: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 219: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 220: Middle East and Africa Market Value (US$ Million) Analysis by Type, 2019 to 2034 Figure 221: Middle East and Africa Market Volume (Vials) Analysis by Type, 2019 to 2034 Figure 222: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2024 to 2034 Figure 223: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034 Figure 224: Middle East and Africa Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034 Figure 225: Middle East and Africa Market Volume (Vials) Analysis by Animal Type, 2019 to 2034 Figure 226: Middle East and Africa Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034 Figure 227: Middle East and Africa Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034 Figure 228: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034 Figure 229: Middle East and Africa Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034 Figure 230: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034 Figure 231: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034 Figure 232: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 233: Middle East and Africa Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034 Figure 234: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 235: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 236: Middle East and Africa Market Attractiveness by Type, 2024 to 2034 Figure 237: Middle East and Africa Market Attractiveness by Animal Type, 2024 to 2034 Figure 238: Middle East and Africa Market Attractiveness by Route of Administration, 2024 to 2034 Figure 239: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 240: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
Recommendations
Explore Healthcare Insights
View Reports